Cue Biopharma, Inc. (CUE)
Latest CUE Insider Trades
About Cue Biopharma, Inc. (CUE)
Cue Biopharma Inc is a clinical-stage therapeutics company focused on advancing a robust portfolio of potentially transformative therapies aimed at enabling functional cures across immunological disorders. Its product pipeline includes CUE-221, an anti-IgE antibody candidate being developed for allergic diseases. The company has also developed the Immuno-STAT platform for targeting disease-related T cells and is developing CUE-401, an IL-2 and TGF-B therapeutic candidate for autoimmune diseases.
- BOSTON, MA
- 29
- 2018
- XNAS
90-Day SEC Filing Activity
| Form 4 transaction type | Transactions | Shares | Total value |
|---|---|---|---|
| Open-market sale | 11 | 72,715 | $2.04M |
| Grant or award | 18 | 1,277,995 | |
| Option exercise | 6 | 282,044 |
CUE Insider Transactions (Form 4)
636 Form 4 filings on record, the earliest from Nov 29, 2024, newest first. Filing history page 2 of 2.
| Date | Insider | Transaction | Security | Shares | Price | Value |
|---|---|---|---|---|---|---|
| Lucinda Warren - Officer | Grant or award | Stock Option (right to buy) | 125,000 |
Recent CUE Form 8-K Filings
5Recent CUE Form 144 Notices of Proposed Sale
2A Form 144 is notice of an INTENDED sale, not a completed one. It often precedes the Form 4 that reports the trade actually happening.
| Filed | Filer | Relationship | Shares | Market value | Notice |
|---|---|---|---|---|---|
| Shao-Lee Lin | Officer, Director | 40,000 | $1.08M | View on EDGAR | |
| Sumita Ray | Officer, CORPORATE SECRETARY |
CUE Insider Trading - FAQ
What is the latest insider trade for CUE?
Cue Biopharma, Inc. (CUE) had 15 insider filings in the last 90 days, with the most recent on 2026-08-28. The full record for CUE runs to 36 Form 4 filings, the earliest from 2024-11-29. InsiderAlpha tracks every Form 4, Form 144, and 8-K filing in real time.
How many insiders are buying CUE stock?
No insider purchases of CUE were filed in the last 90 days. 8 purchases are on record for this company.
How many insiders are selling CUE stock?
11 insider sales of CUE were filed in the last 90 days, totaling $2.04M.
Where can I see CUE SEC filings (Form 4, 10-K, 10-Q, 8-K)?
This page tracks CUE Form 4 insider transactions, Form 144 sale notices, and 8-K material event disclosures in one timeline. Annual 10-K and quarterly 10-Q reports live on the company's SEC EDGAR page.
How can I follow CUE insider buys?
Create a free InsiderAlpha account and press Watch on this page to add CUE to your watchlist. A free account also opens the full scored daily plan with every past day and 3 months of price history. No card is required. Sign up at https://insideralpha.ai/register.
More Health Care Companies with Insider Activity
Recent Insider Filings
10Every Form 4 below links to the original document on SEC EDGAR, so the numbers on this page can be checked against the filing they came from.
- - Pasha Sarraf view on EDGAR
- - Pamela Garzone view on EDGAR
- - Sumita Ray view on EDGAR
- - Michael Vincent Meluzio view on EDGAR
- - Shao-Lee Lin view on EDGAR
- - James M. Ahlers view on EDGAR
- - Shao-Lee Lin view on EDGAR
- - Dominique Christian Borie view on EDGAR
- - Pamela Garzone view on EDGAR
Related Companies - Recent Insider Activity
Learn More
- What is SEC Form 4?
- The filing insiders must submit within two business days of a trade, and how to read its transaction codes.
- Insider activity in Health Care
- Where CUE's peers are being bought and sold.
- Every recent Form 4
- The full market-wide feed, updated as filings arrive from SEC EDGAR.
Track CUE insider activity as it files
Real-time Form 4 alerts, AI-scored daily trade ideas and 10b5-1 plan flags.
